Prescription drug prices are rising, as are tempers. On Dec. 9, a congressional hearing looked into the rising cost of medicine and what appears to be a troubling trend: pharmaceutical companies purchasing already-available drugs and selling them for much higher prices.
Several companies reportedly have done this in recent years, although Turing Pharmaceuticals AG has become the most infamous example. The company received a ton of negative headlines earlier this year for buying the rights to an antiparasitic drug, Daraprim. The 65-year-old drug had been selling for $13.50 a pill; Turing raised the per-pill price to $750.Click to view full article